 |
|
 |
|
Myeloid malignancy
Article watch:
|
 |
Summaries of key papers selected by the editors.
|
|
Review watch:
|
 |
BloodMed exclusives:
|
 |
 |
 |
The best reviews from the journals. |
| |
|
|
|
|
Peer-reviewed articles summarizing hot topics, written
specially for BloodMed.com:
- Immunophenotypic monitoring of residual disease in AML
Sylvie Freeman, Clinical Immunology, Division of Infection and Immunology, University of Birmingham, Birmingham, UK
- Core-binding factor acute myeloid leukemias - time for targeted therapy
Professor J T Reilly, Dept of Hematology, Royal Hallamshire Hospital, Sheffield
- Acquired uniparental disomy in hematological malignancy
Manoj Raghavan, Jude Fitzgibbon, Lan-Lan Smith, T. Andrew Lister, Bryan D. Young, CRUK Medical Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry
|
|
 |
 |
|
Specialist journals:
|
 |
Guideline watch:
|
 |
 |
|
Subspecialty journals by impact factor:
|
|
|
Current clinical guidelines.
- Guidelines on the management of acute myeloid leukaemia in adults.
British Committee for Standards in Haematology (BCSH). Milligan DW, Grimwade D, Cullis JO, Bond L, Swirsky D, Craddock C et al. British Journal of Haematology 2006; 135: 450-74.
- 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline
Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al. Journal of Clinical Oncology 2006; 24: 3187-3205.
- Acute myeloid leukemia clinical practice guidelines in oncology
O' Donnell MR et al. J Natl Compr Canc Netw 2006; 4: 16-36.
|
|
|
Slide atlas:
|
| Latest additions to our slide collection |
|
| |
|
 |
|
 |